Related Experiment Video
Updated: Mar 3, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
[Relationship between Hypercalcemia and Renal Function with Eldecalcitol]
Shinji Oda1, Takayuki Miyoshi1, Kenichi Furuta1
1Department of Pharmacy, Matsuyama Shimin Hospital.
Eldecalcitol (ELD) treatment for osteoporosis can cause hypercalcemia, especially in patients with low kidney function. A baseline estimated glomerular filtration rate (eGFR) below 45.9 mL/min significantly increases this risk.
Area of Science:
- Endocrinology
- Nephrology
- Pharmacology
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Skeleton and Calcium Homeostasis
